HOUSTON – (May 9, 2012) – Research efforts towards the development of a therapeutic vaccine for Chagas disease just got a significant boost through a new agreement between Baylor College of Medicine and SouthWest Electronic Energy Medical Research Institute.
Dr. LaForce Honored for his Integral Role in Developing a New Meningitis Vaccine Washington, D.C. - May 7, 2012 – Today, the Sabin Vaccine Institute presented its annual Albert B. Sabin Gold Medal Award to Dr. F. Marc LaForce for his integral role in developing a new meningitis vaccine, MenAfriVac™, which has the potential to prevent one million cases of disease and save 150,000 lives and up to $300 million in medical costs over the next decade.
We’re scientists. We’re researchers. And we’re advocates for a world free of needless suffering.
We develop new vaccines to combat neglected and global health threats, while simultaneously ensuring that existing and effective treatments get into the hands of people in need. We are particularly committed to saving lives in the world’s areas of greatest neglect, poverty, and destitution. We build bridges between leaders in science, academia, industry and government to conduct critical research to catalyze these solutions.
We’re a non-profit 501(c)(3) organization with generous support from the Bill & Melinda Gates Foundation and other organizations and individuals dedicated to our mission of reducing human suffering from vaccine preventable and neglected tropical diseases. Everyday, our work is lifting people out of poverty, improving and saving lives.
04.27.12 : Immunization Week: Now Reaching 180 Countries to Help Close the Gap in Global Health
[read more]
04.24.12 : Smallpox Eradication Continues to Inspire Innovations in Global Health
[read more]
04.12.12 : Congrats to Dr. Hotez, who was honored with the Ralph Feigin Award at the Annual Luncheon of The Immunization Partnership of Houston.
[read more]